EZM 2302
CAS: 1628830-21-6
Ref. 3D-DQC83021
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
EZM 2302
Descripción:
EZM 2302 is a histone deacetylase (HDAC) inhibitor that inhibits the activity of HDACs, which are enzymes that regulate gene transcription. EZM 2302 has been shown to inhibit the growth of leukemia cells in vitro and in vivo. It has also been shown to inhibit tumorigenesis by halting oncogenic signaling pathways and inducing cell death. EZM 2302 has also been found to be a methyltransferase inhibitor, inhibiting the activity of methyltransferases. This inhibition prevents the production of proteins necessary for cancer development.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
585.09 g/mol
Fórmula:
C29H37ClN6O5
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
